CXCR4 and lung cancer: Activation of CXCR4 and STAT3 results in the initiation of multiple signaling pathways, leading to metastasis and angiogenesis in lung cancer; thus, CXCR4 and STAT3 are potential targets for anti-angiogenic therapy [98].